Comparison of outcome of the Marfan syndrome in patients diagnosed at age ≤6 years versus those diagnosed at 6 years of age

American Journal of Cardiology

Volumn 91, Issue 1, 2003, Pages 102-103

  Yetman, Anji T ^a,b   Huang, Pip ^a   Bornemeier, Renee A ^a   McCrindle, Brian W ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADOLESCENT; ANTIHYPERTENSIVE THERAPY; AORTA ROOT; AORTA SURGERY; ARTICLE; CARDIOVASCULAR DISEASE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FAMILY HISTORY; HUMAN; MARFAN SYNDROME; MITRAL VALVE; MITRAL VALVE REGURGITATION; PRIORITY JOURNAL;

AGE FACTORS; ANALYSIS OF VARIANCE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; ECHOCARDIOGRAPHY; FEMALE; HUMANS; INFANT; MALE; MARFAN SYNDROME;

EID: 0037222904     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(02)03012-6     Document Type: Article

References (13)

1. Marfan A.B. Un cas de deformation congenital des quatre membres plus pronouncee aux extremities characterisee par l'allongement des os avec un certain degre d'amonassesment. Bull Mem Soc Med Hop. 13:1896;220-226.
2. Tsang V.T., Pawade A., Karl T.R., Mee R.B. Surgical management of Marfan syndrome in children. J Card Surg. 9:1994;50-54.
3. Sisk H.E., Zahka K.G., Pyeritz R.E. The Marfan syndrome in early childhood analysis of 15 patients diagnosed at less than 4 years of age . Am J Cardiol. 52:1983;353-358.
4. Loeys B., Nuytinck L., Delvaux I., De Bie S., De Paepe A. Genotype and phenotype analysis of 171 patients referred for molecular study of the fibrillin-1 gene FBN1 because of suspected Marfan syndrome. Arch Intern Med. 161:2001;2447-2454.
5. van Karnebeek C.D.M., Naeff M.S.J., Mulder B.J.M., Hennekam R.C.M., Offringa M. Natural history of cardiovascular manifestations in Marfan syndrome. Arch Dis Child. 84:2001;129-137.
6. Reed C.M., Fox M.E., Alpert B.S. Aortic biomechanical properties in pediatric patients with the Marfan syndrome, and the effects of atenolol. Am J Cardiol. 71:1993;606-608.
7. Jeremy R.W., Huang H., Hwa J., McCarron H., Hughes C.F., Richards J.G. Relation between age, arterial distensibility, and aortic dilatation in the Marfan syndrome. Am J Cardiol. 74:1994;369-373.
8. Groenink M., Rozendaal L., Naeff M.S.J., Hennekam R.C.M., Hart A.A.M., van der Wall E.E., Mulder B.J.M. Marfan syndrome in children and adolescents predictive and prognostic value of aortic root growth for screening for aortic complication . Heart. 80:1998;163-169.
9. Yoshinaga M., Oku S., Nomura Y., Nagai E. A case of Marfan syndrome in an adolescent with aortic dissection should the recommendation for surgical intervention be changed? Ped Cardiol. 20:1999;431-434.
10. De Paepe A., Devereaux R.B., Dietz H.C., Hennekam R.C.M., Pyeritz R.E. Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet. 62:1996;417-426.
11. Roman M.J., Devereaux R.B., Kramer-Fox R., O'Loughlin J. Two dimensional echocardiographic aortic root dimensions in normal children and adults. Am J Cardiol. 64:1989;507-512.
12. Snider A.R., Enderlein M.A., Teitel D.F., Juster R.P. Two-dimensional echocardiographic determination of aortic and pulmonary sizes from infancy to adulthood in normal subjects. Am J Cardiol. 53:1984;218-224.
13. Robinson P.N., Godfrey M. The molecular genetics of Marfan syndrome and related microfibrillopathies. J Med Genet. 37:2000;9-25.